Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × RAD1901 × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Sarcoma, Endometrial Stromal 1 Perivascular Epithelioid Cell Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Central Nervous System Neoplasms 1 Central Nervous System Diseases 1 Breast Diseases 1 Brain Neoplasms 1 Brain Diseases 1 Advanced Breast Cancer 1 Adenosarcoma of the uterus 1

Interventions

Letrozole 4 palbociclib 2 elacestrant 2 Fulvestrant 2 Anastrozole 2 AZD9833 2 trastuzumab deruxtecan 1 sacituzumab govitecan 1 ribociclib 1 exemestane 1 dalpiciclib 1 abemaciclib 1 Selective Estrogen Receptor Modulators 1 RAD1901 1 Gonadotropin-Releasing Hormone 1 Everolimus 1 Bevacizumab 1 Alpelisib 1 AZD5305 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06382948 2026-04-03

ADELA

MedSIR

Phase 3 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡